ESE.AU · eSense-Lab Ltd

-

Please sign in to comment on ESE.AU

1 Comment

Admin

4 years, 1 month ago

eSense-Lab Ltd is currently in a long term uptrend where the price is trading 0.0% above its 200 day moving average.

From a valuation standpoint, the stock is 10.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 229.6.

eSense-Lab Ltd's total revenue sank by 87.5% to $1K since the same quarter in the previous year.

Its net income has dropped by 69.4% to $-1M since the same quarter in the previous year.

Finally, its free cash flow grew by 7.4% to $-376K since the same quarter in the previous year.

Based on the above factors, eSense-Lab Ltd gets an overall score of 3/5.

Industry	Drug Manufacturers - Specialty & Generic
Exchange	AU
CurrencyCode	AUD
ISIN	AU000000ESE9
Sector	Healthcare

Market Cap	9M
PE Ratio	None
Target Price	None
Dividend Yield	0.0%
Beta	1.46

ABOUT

eSense-Lab Ltd

eSense-Lab Ltd, a life sciences research and development company, specializes in the commercialization of phytochemical profiling of plants. It focuses on the development and manufacturing of terpene profiles of the cannabis plant for use in various applications, such as concentrates, medicine, topical treatments, e-liquids, beverages, personalized medicine, cosmetics, and food additives. The company was incorporated in 2016 and is based in Nes Tziona, Israel.

ESE.AU · eSense-Lab Ltd

-

eSense-Lab Ltd

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest eSense-Lab Ltd using a moving average strategy